TNF and ulcerative colitis: Through network pharmacology and molecular docking, we revealed HZ's intricate multi‐compound, multi‐target, and multi‐pathway intervention in promoting ulcerative colitis, specifically within Toll‐like receptor, NF‐kappa B, T cell receptor, and TNF signaling pathways.